MS sunshine study: Sun exposure but not vitamin D is associated with multiple sclerosis risk in blacks and hispanics

Nutrients

Volumn 10, Issue 3, 2018, Pages

  Langer Gould, Annette ^a   Lucas, Robyn ^b   Xiang, Anny H ^a   Chen, Lie H ^a   Wu, Jun ^a   Gonzalez, Edlin ^a   Haraszti, Samantha ^a,c   Smith, Jessica B ^a   Quach, Hong ^d   Barcellos, Lisa F ^d  

^a KAISER PERMANENTE   (United States)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blacks; Hispanics; Multiple sclerosis; Sun exposure; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; HLA ANTIGEN CLASS 2;

ADULT; ARTICLE; BLACK PERSON; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTRONIC HEALTH RECORD; FEMALE; GENOTYPE; HISPANIC; HUMAN; LIFESPAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; QUESTIONNAIRE; SUN EXPOSURE; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RADIATION; VITAMIN D DEFICIENCY; ALLELE; BLOOD; BODY MASS; CALIFORNIA; CASE CONTROL STUDY; CAUCASIAN; COMPLICATION; DIETARY SUPPLEMENT; EPIDEMIOLOGY; ETHNOLOGY; GENETICS; GENOTYPING TECHNIQUE; INCIDENCE; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SUNLIGHT; YOUNG ADULT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BODY MASS INDEX; CALIFORNIA; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPING TECHNIQUES; HISPANIC AMERICANS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SUNLIGHT; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 85042646170     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10030268     Document Type: Article

References (46)

1. Munger, K.L.; Levin, L.I.; Hollis, B.W.; Howard, N.S.; Ascherio, A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296, 2832–2838. [CrossRef] [PubMed]
2. Lucas, R.M.; Ponsonby, A.L.; Dear, K.; Valery, P.C.; Pender, M.P.; Taylor, B.V.; Kilpatrick, T.J.; Dwyer, T.; Coulthard, A.; Chapman, C.; et al. Sun exposure and vitamin D are independent risk factors for cns demyelination. Neurology 2011, 76, 540–548. [CrossRef] [PubMed]
3. Salzer, J.; Hallmans, G.; Nystrom, M.; Stenlund, H.; Wadell, G.; Sundstrom, P. Vitamin D as a protective factor in multiple sclerosis. Neurology 2012, 79, 2140–2145. [CrossRef] [PubMed]
4. Ascherio, A.; Munger, K.L. Epidemiology of multiple sclerosis: From risk factors to prevention-an update. Semin. Neurol. 2016, 36, 103–114. [CrossRef] [PubMed]
5. Ross, A.C.; Taylor, C.L.; Yaktine, A.L.; Del Valle, H.B. (Eds.) Dietary Reference Intakes for Calcium and Vitamin D; National Academies Press: Washington, DC, USA, 2011.
6. Yetley, E.A. Assessing the vitamin D status of the us population. Am. J. Clin. Nutr. 2008, 88, 558S–564S. [CrossRef] [PubMed]
7. Langer-Gould, A.; Brara, S.M.; Beaber, B.E.; Zhang, J.L. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology 2013, 80, 1734–1739. [CrossRef] [PubMed]
8. Wallin, M.T.; Culpepper, W.J.; Coffman, P.; Pulaski, S.; Maloni, H.; Mahan, C.M.; Haselkorn, J.K.; Kurtzke, J.F. Veterans Affairs Multiple Sclerosis Centres of Excellence Epidemiology. The gulf war era multiple sclerosis cohort: Age and incidence rates by race, sex and service. Brain 2012, 135, 1778–1785. [CrossRef] [PubMed]
9. Divers, J.; Register, T.C.; Langefeld, C.D.; Wagenknecht, L.E.; Bowden, D.W.; Carr, J.J.; Hightower, R.C.; Xu, J.; Hruska, K.A.; Freedman, B.I. Relationships between calcified atherosclerotic plaque and bone mineral density in african americans with type 2 diabetes. J. Bone Miner. Res. 2011, 26, 1554–1560. [CrossRef] [PubMed]
10. Cauley, J.A.; Danielson, M.E.; Boudreau, R.; Barbour, K.E.; Horwitz, M.J.; Bauer, D.C.; Ensrud, K.E.; Manson, J.E.; Wactawski-Wende, J.; Shikany, J.M.; et al. Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: The women’s health initiative (whi). J. Bone Miner. Res. 2011, 26, 2378–2388. [CrossRef] [PubMed]
11. Acheson, E.D.; Bachrach, C.A.; Wright, F.M. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr. Scand. Suppl. 1960, 35, 132–147. [CrossRef] [PubMed]
12. Elmets, C.A.; Cala, C.M.; Xu, H. Photoimmunology. Dermatol. Clin. 2014, 32, 277–290. [CrossRef] [PubMed]
13. Fajuyigbe, D.; Young, A.R. The impact of skin colour on human photobiological responses. Pigment Cell Melanoma Res. 2016, 29, 607–618. [CrossRef] [PubMed]
14. Koebnick, C.; Langer-Gould, A.; Gould, M.K.; Chao, C.R.; Iyer, R.L.; Smith, N.; Chen, W.; Jacobesen, S.J. Do the sociodemographic characteristics of members of a large, integrated health care system represent the population of interest? Perm. J. 2012, 16, 37–41. [CrossRef] [PubMed]
15. Langer-Gould, A.; Wu, J.; Lucas, R.; Smith, J.; Gonzales, E.; Amezcua, L.; Haraszti, S.; Chen, L.H.; Quach, H.; James, J.A.; et al. Epstein-barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study. Neurology 2017, 89, 1330–1337. [CrossRef]
16. Langer-Gould, A.; Zhang, J.L.; Chung, J.; Yeung, Y.; Waubant, E.; Yao, J. Incidence of acquired cns demyelinating syndromes in a multiethnic cohort of children. Neurology 2011, 77, 1143–1148. [CrossRef] [PubMed]
17. Polman, C.H.; Reingold, S.C.; Banwell, B.; Clanet, M.; Cohen, J.A.; Filippi, M.; Fujihara, K.; Havrdova, E.; Hutchinson, M.; Kappos, L.; et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the mcdonald criteria. Ann. Neurol. 2011, 69, 292–302. [CrossRef] [PubMed]
18. Jacob, A.; Weinshenker, B.G. An approach to the diagnosis of acute transverse myelitis. Semin. Neurol. 2008, 28, 105–120. [CrossRef] [PubMed]
19. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59, 499–505.
20. Pritchard, J.K.; Stephens, M.; Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 2000, 155, 945–959. [PubMed]
21. Purcell, S.; Neale, B.; Todd-Brown, K.; Thomas, L.; Ferreira, M.A.; Bender, D.; Maller, J.; Sklar, P.; de Bakker, P.I.; Daly, M.J.; et al. Plink: A tool set for whole–genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81, 559–575. [CrossRef] [PubMed]
22. King, L.; Xiang, F.; Swaminathan, A.; Lucas, R.M. Measuring sun exposure in epidemiological studies: Matching the method to the research question. J. Photochem. Photobiol. B 2015, 153, 373–379. [CrossRef] [PubMed]
23. Van der Mei, I.A.; Blizzard, L.; Ponsonby, A.L.; Dwyer, T. Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis. Cancer Epidemiol. Biomark. Prev. 2006, 15, 1538–1544. [CrossRef] [PubMed]
24. Lucas, R.M.; Ponsonby, A.L.; Dear, K.; Taylor, B.V.; Dwyer, T.; McMichael, A.J.; Valery, P.; Van der Mei, I.; Williams, D.; Pender, M.P.; et al. Associations between silicone skin cast score, cumulative sun exposure, and other factors in the ausimmune study: A multicenter australian study. Cancer Epidemiol. Biomark. Prev. 2009, 18, 2887–2894. [CrossRef] [PubMed]
25. Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M.; Endocrine, S. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911–1930. [CrossRef] [PubMed]
26. Reis, J.P.; Michos, E.D.; Selvin, E.; Pankow, J.S.; Lutsey, P.L. Race, vitamin d-binding protein gene polymorphisms, 25–hydroxyvitamin D, and incident diabetes: The atherosclerosis risk in communities (aric) study. Am. J. Clin. Nutr. 2015, 101, 1232–1240. [CrossRef] [PubMed]
27. Wang, W.; Ingles, S.A.; Torres-Mejia, G.; Stern, M.C.; Stanczyk, F.Z.; Schwartz, G.G.; Nelson, D.O.; Fejerman, L.; Wolff, R.K.; Slattery, M.L.; et al. Genetic variants and non-genetic factors predict circulating vitamin D levels in hispanic and non-hispanic white women: The breast cancer health disparities study. Int. J. Mol. Epidemiol. Genet. 2014, 5, 31–46. [PubMed]
28. Rhead, B.; Baarnhielm, M.; Gianfrancesco, M.; Mok, A.; Shao, X.; Quach, H.; Shen, L.; Schaefer, C.; Link, J.; Gyllenberg, A.; et al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol. Genet. 2016, 2, e97. [CrossRef] [PubMed]
29. Mokry, L.E.; Ross, S.; Ahmad, O.S.; Forgetta, V.; Smith, G.D.; Goltzman, D.; Leong, A.; Greenwood, C.M.; Thanassoulis, G.; Richards, J.B. Vitamin D and risk of multiple sclerosis: A mendelian randomization study. PLoS Med. 2015, 12, e1001866. [CrossRef] [PubMed]
30. Ahn, J.; Yu, K.; Stolzenberg-Solomon, R.; Simon, K.C.; McCullough, M.L.; Gallicchio, L.; Jacobs, E.J.; Ascherio, A.; Helzlsouer, K.; Jacobs, K.B.; et al. Genome–wide association study of circulating vitamin D levels. Hum. Mol. Genet. 2010, 19, 2739–2745. [CrossRef] [PubMed]
31. Wang, T.J.; Zhang, F.; Richards, J.B.; Kestenbaum, B.; van Meurs, J.B.; Berry, D.; Kiel, D.P.; Streeten, E.A.; Ohlsson, C.; Koller, D.L.; et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010, 376, 180–188. [CrossRef]
32. Baarnhielm, M.; Hedstrom, A.K.; Kockum, I.; Sundqvist, E.; Gustafsson, S.A.; Hillert, J.; Olsson, T.; Alfredsson, L. Sunlight is associated with decreased multiple sclerosis risk: No interaction with human leukocyte antigen-drb1*15. Eur J. Neurol. 2012, 19, 955–962. [CrossRef] [PubMed]
33. Ullrich, S.E.; Byrne, S.N. The immunologic revolution: Photoimmunology. J. Investig. Dermatol. 2012, 132, 896–905. [CrossRef] [PubMed]
34. Wang, Y.; Marling, S.J.; Beaver, E.F.; Severson, K.S.; Deluca, H.F. Uv light selectively inhibits spinal cord inflammation and demyelination in experimental autoimmune encephalomyelitis. Arch. Biochem. Biophys. 2015, 567, 75–82. [CrossRef] [PubMed]
35. Hart, P.H.; Lucas, R.M.; Booth, D.R.; Carroll, W.M.; Nolan, D.; Cole, J.M.; Jones, A.P.; Kermode, A.G. Narrowband uvb phototherapy for clinically isolated syndrome: A trial to deliver the benefits of vitamin D and other uvb–induced molecules. Front. Immunol. 2017, 8, 3. [CrossRef] [PubMed]
36. Becklund, B.R.; Severson, K.S.; Vang, S.V.; DeLuca, H.F. Uv radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc. Natl. Acad. Sci. USA 2010, 107, 6418–6423. [CrossRef] [PubMed]
37. Speeckaert, M.M.; Speeckaert, R.; van Geel, N.; Delanghe, J.R. Vitamin D binding protein: A multifunctional protein of clinical importance. Adv. Clin. Chem. 2014, 63, 1–57. [PubMed]
38. Gutierrez, O.M.; Farwell, W.R.; Kermah, D.; Taylor, E.N. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the national health and nutrition examination survey. Osteoporos. Int. 2011, 22, 1745–1753. [CrossRef] [PubMed]
39. Langer-Gould, A.; Lucas, R.M.; Xiang, A.H.; Wu, J.; Chen, L.H.; Gonzales, E.; Haraszti, S.; Smith, J.B.; Quach, H.; Barcellos, L.F. Vitamin D-binding protein polymorphisms, 25-hydroxyvitamin D, sunshine and multiple sclerosis. Nutrients 2018, 10, 184. [CrossRef] [PubMed]
40. Simmons, R.D.; Ponsonby, A.L.; van der Mei, I.A.; Sheridan, P. What affects your ms? Responses to an anonymous, internet–based epidemiological survey. Mult. Scler. 2004, 10, 202–211. [CrossRef] [PubMed]
41. Gelfand, J.M.; Cree, B.A.; McElroy, J.; Oksenberg, J.; Green, R.; Mowry, E.M.; Miller, J.W.; Hauser, S.L.; Green, A.J. Vitamin D in African Americans with multiple sclerosis. Neurology 2011, 76, 1824–1830. [CrossRef] [PubMed]
42. Rito, Y.; Flores, J.; Fernandez Aguilar, A.; Escalante Membrillo, C.; Gutierrez Lanz, E.; Barboza, M.A.; Rivas Alonso, V.; Trevino Frenk, I.; Corona Vazquez, T. Vitamin D in multiple sclerosis patients: Not the same risk for everybody. Mult. Scler. 2016, 22, 126–127. [CrossRef] [PubMed]
43. Amezcua, L.; Chung, R.H.; Conti, D.V.; Langer-Gould, A.M. Vitamin D levels in hispanics with multiple sclerosis. J. Neurol. 2012, 259, 2565–2570. [CrossRef] [PubMed]
44. Hofmann, J.N.; Yu, K.; Horst, R.L.; Hayes, R.B.; Purdue, M.P. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol. Biomark. Prev. 2010, 19, 927–931. [CrossRef] [PubMed]
45. Autier, P.; Mullie, P.; Macacu, A.; Dragomir, M.; Boniol, M.; Coppens, K.; Pizot, C.; Boniol, M. The influence of vitamin D supplementation on non–skeletal conditions: A systematic review of randomised trials and of their meta-analyses. Lancet Diabetes Endocrinol. 2017, 5, 986–1002. [CrossRef]
46. Bischoff-Ferrari, H.A.; Dawson-Hughes, B.; Orav, E.J.; Staehelin, H.B.; Meyer, O.W.; Theiler, R.; Dick, W.; Willett, W.C.; Egli, A. Monthly high-dose vitamin D treatment for the prevention of functional decline: A randomized clinical trial. JAMA Intern. Med. 2016, 176, 175–183. [CrossRef] [PubMed]